In this section you can find business information covering life science companies\' R&D pipelines. Reports can including disease hub, description, therapeutic indication, mechanism of action, drug class, current trial information, trial details and partnering detail, product revenue, trademarks, corporate partners and management profiles.

Stay up-to-date with new products added to this category »

Results 1 - 30 of 568
1
2
3
4
5
6
7
8
9
10
11

Title	Publication Date	Price
Substance (Drug) Abuse - Pipeline Review H1 2012	January 2012	£325
Open-Angle Glaucoma - Pipeline Review H1 2012	January 2012	£325
Urinary Tract Cancer - Pipeline Review H1 2012	January 2012	£325
Mantle Cell Lymphoma - Pipeline Review H1 2012	January 2012	£325
T-Cell Leukemia - Pipeline Review H1 2012	January 2012	£325
Diabetic Gastroparesis - Pipeline Review H1 2012	January 2012	£325
Lymphoma - Pipeline Review H1 2012	January 2012	£325
Malignant Mesothelioma - Pipeline Review H1 2012	January 2012	£325
Vancomycin-Resistant Enterococcus Faecium Infections - Pipeline Review H1 2012	January 2012	£325
Intra Dialytic Hypotension - Pipeline Review H1 2012	January 2012	£325
Ovarian Cancer - Pipeline Review H1 2012	January 2012	£325
Helicobacter Pylori Infections - Pipeline Review H1 2012	January 2012	£325
Essential Thrombocythemia - Pipeline Review H1 2012	January 2012	£325
Esophageal Cancer - Pipeline Review H1 2012	January 2012	£325
Diabetic Foot Infection (DFI) - Pipeline Review H1 2012	January 2012	£325
Myocardial Infarction - Pipeline Review H1 2012	January 2012	£325
Rectal Cancer - Pipeline Review H1 2012	January 2012	£325
Myocardial Ischemia - Pipeline Review H1 2012	January 2012	£325
Medulloblastoma - Pipeline Review H1 2012	January 2012	£325
Lung Transplantation - Pipeline Review H1 2012	January 2012	£325
Clostridium Infections - Pipeline Review H1 2012	January 2012	£325
Neisseriaceae Infections - Pipeline Review H1 2012	January 2012	£325
Small Intestine Cancer - Pipeline Review H1 2012	January 2012	£325
Nasopharyngitis (Common Cold) - Pipeline Review H1 2012	January 2012	£325
Natural Killer Cell Lymphomas - Pipeline Review H1 2012	January 2012	£325
Medullary Thyroid Cancer - Pipeline Review H1 2012	January 2012	£325
Chemotherapy Effects - Pipeline Review H1 2012	January 2012	£325
Primary Immune Deficiency (PID) - Pipeline Review H1 2012	January 2012	£325
Hypoglycemia - Pipeline Review H1 2012	January 2012	£325
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline Review H1 2012	January 2012	£325

Results 1 - 30 of 568
1
2
3
4
5
6
7
8
9
10
11

Receive latest news